Results 141 to 150 of about 132,571 (292)
Management of Lost Atherectomy Devices in the Coronary Arteries
ABSTRACT Rotational and orbital atherectomy are important tools to treat calcific coronary disease. Entrapment of an atherectomy device, that is, rotational atherectomy burr or orbital atherectomy crown, is a serious complication during atherectomy. Loss of an atherectomy device is a more challenging complication that usually follows device entrapment.
Gregor Leibundgut+8 more
wiley +1 more source
Impact of Kidney Function on Physiological Assessment of Coronary Circulation. [PDF]
Zasada W+8 more
europepmc +1 more source
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli+3 more
wiley +1 more source
Role of Computed Tomography Findings in Diagnosing Pulmonary Atresia With Intact Ventricular Septum and Right Ventricle-Dependent Coronary Circulation: A Case Report. [PDF]
Thurmann KE, Richardson RR.
europepmc +1 more source
Cutting‐Edge Aptasensing Approaches for Electrochemical Detection of Exosomes Utilizing MXenes
This work notably summarizes research on 2D MXenes/MXene's‐hybrid‐based nanoplatforms patterned with aptamers as an alternative to antibodies affording highly sensitive and robust biosensing of exosomes as well as their efficient isolation. The exosomes are highlighted as a valuable source of biomarkers and with the immobilization approaches of ...
Andrej Vikartovský+5 more
wiley +1 more source
Pathophysiology of coronary circulation [PDF]
openaire +6 more sources
Time-Dependent Changes in the Coronary Circulation Triggered by CTO Revascularization: Insights From Intracoronary Physiology. [PDF]
Lombardi M+6 more
europepmc +1 more source
Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou+6 more
wiley +1 more source